Medicare beneficiaries get a new pathway to access certain GLP-1s for weight loss or weight maintenance for $50 per fill
Another review showed no effect of berberine on body weight
Journal of Clinical Medicine, 12(18), 5915
Home Wirkstoffgruppen Glucagon-like peptide 1 (GLP-1-)Rezeptoragonisten (Inkretinmimetika) werden zur Behandlung von Diabetes mellitus Typ 2 in Kombination mit anderen Antidiabetika oder als Monotherapie, wenn Metformin nicht indiziert ist, eingesetzt
Patients taking GLP-1 drugs lose weight faster, but they may experience side effects, such as nausea, vomiting, diarrhea, indigestion, fatigue, dizziness, and hypoglycemia, along with other potential adverse events
Semaglutide and weight loss in patients with obesity